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Abstract
Purpose of review: Metastatic melanoma is the most aggressive skin
cancer and despite tremendous efforts and considerable progress in
clinical treatment of melanoma patients within recent years, it
remains a deadly disease. Current treatments affect melanoma cells
indiscriminately, while accumulating evidence suggests that
melanoma might be a disease of stem cells. This review aims to
summarize the important accomplishments in the field and to
emphasize the common molecular and cellular mechanisms
regulating self-renewal of neural crest stem cells (NCSCs) and
melanoma cells.
Recent findings: A growing number of publications highlight the
existence of phenotypic and functional similarities between
embryonic NCSCs and melanoma cells. These studies provide
compelling evidence that the propagation of melanoma cells
critically depends on genes instrumental in neural crest
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development. The example of Sox10 and Rac1 genes provides
detailed illustration of how interfering with these important genes for
neural crest development can prevent melanoma formation.
Summary: The development of new therapies, targeting
RAF-MEK-ERK pathway, provided major improvements in outcomes
for patients with metastatic melanoma; however, acquired resistance
followed by tumor recurrence represents a major clinical challenge.
The striking parallels between embryonic NCSCs (eNCSCs) and
melanoma cells might lead to the development of new targeted
therapeutics selectively eliminating cell populations accountable for
tumor initiation, progression and relapse.
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INTRODUCTION
Melanoma is a highly heterogeneous tumor and, in addition to
melanocytes, is often composed of cells with neuronal, glial,
chondrocytic and adipocytic features [1–4]. Several recent publications
[5–7] strongly suggest that melanoma contains cells with neural
crest-like characteristics, which are able to sustain the tumor growth
and give rise to distant metastases in vivo. Recent functional studies
provide compelling evidence that interfering with the maintenance of
neural crest stem cells (NCSCs) by either applying chemical
compounds suppressing neural crest development [8] or by
deregulating genes crucial for the self-renewal of embryonic NCSCs
(eNCSCs) [9[black small square],10[black small square]] leads to a
profound suppressive effect on melanoma propagation in vitro and in
vivo.
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THE ROLE OF NEURAL CREST STEM CELLS IN
EMBRYONIC AND ADULT TISSUE HOMEOSTASIS
Neural crest cells represent a transient and highly
migratory embryonic cell population, characterized
by multipotent and self-renewal capacities [11].
During embryonic development, NCSCs give rise
to a plethora of different cell types including glia,
neurons, smooth muscle cells, adipocytes,
osteoblasts, chondrocytes and melanocytes (Fig.
1). For a long time it was generally accepted that
NCSCs exist only in the developing embryo, but a
groundbreaking study by Kruger and colleagues
[12] demonstrated that cells with neural crest
features similar to the one of eNCSCs reside in the
adult gut. This finding triggered a number of
studies, which identified the presence of
postmigratory NCSCs in a variety of adult organs
such as dorsal root ganglia [13,14], heart [15,16],
carotid body [17], cornea [18,19], bone marrow
[14], dental pulp and periodontal ligament [20,21],
and skin [22–27]. Despite a substantial number of
reports on the existence of adult NCSCs in the
adult tissues, the physiological role of these cells
remains poorly understood.
Figure 1
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FF1_113_18_0_Figure 1 FIGURE 1. The embryonic neural crest cells. Neural
crest cells arise in the ectoderm at the margins of the neural tube and, after
extensive migration, settle down in different parts of the body giving rise to a
variety of derivatives including melanocytes, neurons, glial cells, smooth muscle
cells, adipocytes, osteoblasts and chondrocytes.
A recent report by the Miller group [28[black small square][black small
square]] describes, for the first time, the role of neural crest precursor
cells in wound healing in the adult mouse skin. Previously, Miller and
colleagues identified multipotent, self-renewing cells residing in the
adult skin and named these stem cells skin-derived precursor (SKP)
cells [22]. The subsequent research demonstrated that SKPs exhibit
neural crest-like features, as revealed by the expression of neural crest
markers and their differentiation potential [23]. Moreover, genetic
lineage tracing using Wnt1-Cre R26R mice identified SKPs as cells
derived from the neural crest lineage [23]. The observations that the
presence of innervation is crucial for organ regeneration in amphibians
[29] and that neural crest-derived Schwann cells provide signals for
successful tissue repair, prompted Miller and colleagues to investigate
whether the cells associated with the nerve terminals surrounding the
bulge area of the hair follicle might play an essential role in mammalian
tissue repair. They demonstrated that these nerve terminal-associated
cells expressed the transcription factor Sox2 together with other
markers of neural crest cells such as p75NTR, nestin and S100[beta]
[28[black small square][black small square]]. Following wounding of the
skin, some Sox2-positive cells started to proliferate and migrated into
the regenerating dermis. Moreover, the genetic ablation of Sox2
resulted in a significantly decreased rate of wound closure, providing
crucial evidence that the presence of Sox2-positive neural crest-derived
cells is essential for the successful repair of injured skin. Given the
similarities between wound healing and cancer development, it is
intriguing to think that NCSCs in addition to the newly established role in
wound healing, might play a pivotal role in the initiation and
maintenance of cancers such as melanoma.
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COMMON GENE NETWORKS LINK MELANOMA WITH
EMBRYONIC NEURAL CREST CELLS
The fact that in recent years, the number of studies dissecting
remarkable parallels between self-renewal of NCSCs and melanoma
cells is significantly growing, suggests that the understanding of the
molecular and cellular mechanisms underlying NCSC biology might
lead to novel approaches for the improvement of melanoma therapies.
The substantial knowledge of gene regulatory networks controlling
self-renewal of classical eNCSCs is prompting investigation into the role
of molecules crucial for the maintenance of eNCSCs; however, several
recent reports address the role of factors important to sustain also
postmigratory targets of neural crest cells.
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A prime example of a gene crucial for the
self-renewal of eNCSCs is Sox10, a transcription
factor that belongs to the Sox [Sry (sex
determining region Y)-related HMG box] genes
family, playing key roles in embryonic development
and in the regulation of stem cell activity in various
tissues [30]. Sox10 is expressed throughout
embryonic neural crest development and it was
identified as the gene mutated in Dom mice
(Dominant megacolon). Considering that Sox10
governs cell fate decisions during embryonic
development, it is therefore not surprising that
Sox10 haploinsufficiency causes Waardenburg
Hirschsprung syndrome, characterized by a
ganglionic megacolon due to the loss of ganglion
cells, pigmentary abnormalities due to the lack of
melanocytes and often deafness due to the loss of
sensory innervation (Table 1) [9[black small
square],10[black small square],31,32,33[black
small square][black small square]].
Table 1
TT1_114_23_0_Table 1 Table 1 The role of Sox10 in different neural crest-
derived cells during embryonic and postnatal development, giant congenital naevi
and melanoma formation
Genetic studies established that Sox10 is critical for self-renewal and
the survival of NCSCs during embryonic development [34,35]. Mouse
embryos homozygous for the Sox10Dommutation entirely lack neural
crest-derived melanocytes, it still remains unclear, however, whether
this effect is due to the lack of NCSCs, giving rise to committed
melanoblasts or, alternatively, due to the decreased survival of
committed melanocytic progenitors [35,36]. Until recently, perinatal
lethality resulting from disruption of Sox10 gene precluded the analysis
of the Sox10 role in a cell type-specific manner; however the generation
of a conditional allele of Sox10 permitted such analysis [32]. A recent
study by Harris et al.[33[black small square][black small square]]
established that Sox10 is also crucial to sustain the melanocytic lineage
in the adult murine skin (Table 1). Melanocytic lineage in the trunk skin
is composed of two cell populations, located within the hair follicle and
separated based on their anatomical location: the melanocyte stem
cells which reside in the bulge region, and the differentiated
melanocytes occupying the hair follicular bulb [37]. Functional disruption
of the melanocyte stem cells leads to hair graying due to their inability to
generate differentiated melanocytes [38]. The homozygous ablation of
Sox10 in the postnatal melanocytic lineage using a Tyr-CreERT2 mouse
line induces hair graying, accompanied by the lack of the differentiated
melanocytes in the hair follicular bulb and the permanent reduction in
the number of bulge-associated melanocyte stem cells (Table 1).
Surprisingly, similar to Sox10 knockout mice, Sox10 overexpressing
transgenic mice exhibit hair graying, suggesting that the levels of Sox10
expression are essential for the normal physiology of melanocyte stem
cells [33[black small square][black small square]].
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In addition to the role of Sox10 in the normal melanocytic lineage, we
have recently highlighted the role of Sox10 in pathological melanocytic
lesions, such as giant congenital naevi, and melanoma (Table 1)
[9[black small square]]. We demonstrated that the vast majority of
human and mouse giant congenital naevi and melanoma expressed
SOX10 and that Sox10 expression is regulated by NrasQ61Koncogene.
To investigate the role of Sox10 in melanoma in vivo, we have used the
Tyr::NrasQ61KInk4a-/-mouse model of melanoma and showed that
Sox10 haploinsufficiency completely prevented the formation of giant
congenital naevi and melanoma without affecting the normal functions
of neural crest derivatives (Table 1). To address whether Sox10
haploinsufficiency can also interfere with already established naevi, we
have made use of conditional allele of Sox10[32]. Sox10 loss in the skin
of Tyr::NrasQ61Kmice resulted in the complete abolishment of NrasQ61K-
induced hyperpigmentation and subsequent naevi formation, suggesting
that interfering with Sox10 levels can be beneficial for the patients with
giant congenital naevi, who have an increased risk of melanoma
formation. Furthermore, we have silenced SOX10 expression in
established human melanoma cell lines and observed that melanoma
cells displayed decreased proliferation, increased apoptosis and
aberrant differentiation, effects strikingly resembling the effects of Sox10
deletion in eNCSCs, and ultimately leading to the death of the cancer
cells [9[black small square]]. Recently, another study examined the role
of Sox10 in melanoma pathogenesis (Table 1) [10[black small square]].
Similarly to our findings, Pavan and colleagues demonstrated the
requirement of Sox10 for the proliferation of melanoma cells in vitro and
in vivo. Sox10 haploinsufficiency reduced the number of pigmented
naevi and delayed melanoma formation in the Grm1Tg(glutamate
receptor) mouse model for melanoma (Table 1) [10[black small square]].
Mechanistically, SOX10 knockdown resulted in decreased levels of the
transcription factor E2F1 and retinoblastoma protein (Rb), key
components of the cell cycle progression, regulating the progression
through the G1 phase of the cell cycle [10[black small square]].
Moreover, the expression of CDK inhibitors, p21 and p27 were
increased upon SOX10 knockdown, suggesting that SOX10 regulates
cell proliferation and cell cycle progression via multiple, convergent
pathways. Taken together, these studies suggest that Sox10 might be a
promising therapeutic target for the treatment of giant congenital naevi
and melanoma.
In contrast to Sox10, which orchestrates both embryonic and adult
neural crest-derived stem cell populations, Rac1 is an example of a
molecule whose functions are restricted to the maintenance of
postmigratory NCSCs [39]. Rac1 is a member of the Ras-related Rho
family of small guanosinetriphosphatases (GTPases) and is involved in
many cellular processes such as proliferation, actin cytoskeletal
rearrangements, survival and invasiveness [40]. Rac1-deficient NCSCs
display impaired cell cycle control, reduced proliferation and
self-renewal and as a consequence, give rise to neural crest-derived
structures reduced in size [39]. Embryos lacking Rac1 are characterized
by severe defects in the craniofacial and peripheral nervous system
development [39,41]. Interestingly, Rac1 deletion selectively affects
postmigratory NCSCs, whereas neural crest cells emigrating from the
neural tube do not depend on Rac1 function.
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
5 von 14 13.01.2017 13:53
Recently, the identification of an activating mutation in the RAC1 gene
(RAC1P29S) was described in about 10% of human melanoma samples
and is the third most frequent mutation in human melanoma after those
of NRAS and BRAF[42[black small square],43[black small square]]. In a
recent study Machesky and colleagues addressed the role of Rac1 in
the Tyr::NrasQ61KInk4a-/- mouse model of melanoma in vivo and
showed that Rac1 functions downstream of NrasQ61Kand that the
genetic ablation of Rac1 resulted in a decreased number of
melanocytes and led to pigmentation defects in the skin [44[black small
square]]. Importantly, pharmacological inhibition of Rac1 using
Rac-specific inhibitors (NSC23766 and EHT1864) resulted in a
significantly reduced proliferation of NrasQ61Kmelanoma cells [44[black
small square]]. Previous studies showed that the Rac1V12 mutation,
which induces a constitutive activation of Rac1, leads to anchorage-
independent growth in soft agar and is able to induce tumors in vivo
upon transplantation in immunocompromised mice [45], suggesting that
V12Rac1 can act as an oncogene. However, the expression of
constitutively active RAC1V12in zebrafish in vivo is neither sufficient to
induce melanoma formation alone, nor cooperates with BRAFV600E, but
accelerates HRASV12-induced melanoma nodule formation in vivo[46]. It
is somewhat puzzling that RAC1V12 is not sufficient to induce melanoma
formation in zebrafish in vivo, whereas the RAC1P29Smutation leads to
increased proliferation and migration of cultured melanocytes [42[black
small square],46]. Taken together, these findings identify Rac1 as a
potential novel candidate target for melanoma therapy. Studies of the
role of RAC1 in other cancer types, such as breast [47], colorectal [48],
testicular [49], gastric [50], cervical [51], and nonsmall cell lung cancer
[52] might help to unravel the precise molecular mechanisms underlying
RAC1 function in melanoma.
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CANCER STEM CELLS IN TUMOR PROGRESSION:
IN-VIVO LINEAGE TRACING
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One of the most exciting concepts in cancer biology over the last
several years is that cancer might be a disease of stem cells. Although
various studies have attempted to address this issue in melanoma, the
results remain controversial and await further experimental validation.
The recent studies in the field of melanoma research relied on the
isolation of a specific subpopulation of cancer cells based on the
expression of specific cell-surface markers followed by transplantation
into immunocompromised mice [6,53,54]. There are a number of
limitations of such experimental setup, namely the destruction of the
endogenous microenvironment, the lack of supporting niche due to the
transplantation of melanoma cells into the subcutaneous layer of the
skin, and the lack of the immune system, all conditions ultimately
changing the behavior of cancer cells [55]. Transplantation experiments
assess therefore the potential of cancer cells to form tumors rather than
following the fate of cancer cells in their natural environment. The
emergence of recent novel experimental strategies in other types of
cancers might provide an interesting opportunity for future experiments
also in the melanoma field. Tracking tumor cells in vivo using genetic
approaches has become experimentally possible as demonstrated by
three independent groups last year [56[black small square][black small
square]–58[black small square][black small square]]. The results
obtained for tumors of the skin, the brain and the gut provide the
evidence that a small subset of cancer cells sustains tumor growth and
importantly that, by specifically targeting these rare cells, cancer can be
cured. Parada and colleagues evaluated the role of Nestin-positive cells
in sustaining the growth of glioblastoma, the most aggressive brain
tumor [57[black small square][black small square]]. Using a genetically
engineered mouse model of glioma, they could show that the selective
eradication of Nestin-positive cells resulted in the increased survival of
glioblastoma mice and moreover, Nestin-expressing cells were
responsible for the glioblastoma relapse after treatment with
temozolomide. In another study, Clevers and colleagues addressed
whether Lgr5 (leucine-rich repeat-containing heterotrimeric guanine
nucleotide-binding protein-coupled receptor 5), a marker of adult stem
cells in the intestinal crypt, labels the cells sustaining the growth of
intestinal adenomas [58[black small square][black small square]]. Using
the multicolor reporter mouse R26R-Confetti, which allows to label and
to distinguish individual intestinal cells, Schepers et al.[58[black small
square][black small square]] showed that Lgr5-positive cells not only
self-renew and give rise to new Lgr5-positive cells within adenomas but
also generate all other adenoma cell types. Finally, Blanpain and
colleagues tested the concept of cancer stem cells in mouse models of
skin papilloma and invasive squamous cell carcinoma [56[black small
square][black small square]]. In benign skin papilloma, genetic lineage
tracing and clonal analysis of individual tumor cells at different stages of
tumor progression revealed the existence of two distinct cell
populations, the fast cycling fraction with limited self-renewal and the
slow cycling subpopulation with stem cell-like features. In contrast to
benign tumors, a single cell population, generating highly
undifferentiated tumorigenic clones, sustained invasive squamous
carcinoma. The future research will need to address the unique
characteristics of cancer stem cell populations in order to eradicate the
cells responsible for tumor propagation.
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Future studies are needed to determine the expression profile of
melanoma stem cells versus normal NCSCs and the identification of the
markers exclusively expressed by melanoma stem cells. A major
challenge will be to selectively eliminate the NCSCs maintaining
melanoma growth and progression without affecting the pool of normal
NCSCs required to sustain healthy tissue homeostasis. In particular,
Sox10 haploinsufficiency might serve as a good example of such
strategy because it completely abolishes melanoma formation without
affecting neural crest derivatives in the healthy tissue.
Back to Top
Acknowledgements
None.
Back to Top
Conflicts of interest
There are no conflicts of interest.
Back to Top
REFERENCES AND RECOMMENDED READING
Papers of particular interest, published within the annual period of
review, have been highlighted as:
[black small square] of special interest
[black small square][black small square] of outstanding interest
Back to Top
REFERENCES
1. Banerjee SS, Eyden B. Divergent differentiation in malignant
melanomas: a review. Histopathology 2008; 52:119–129. SFX
[Context Link]
2. Cruz J, Reis-Filho JS, Lopes JM. Primary cutaneous malignant
melanoma with lipoblast-like cells. Arch Pathol Lab Med 2003;
127:370–371. SFX [Context Link]
3. Mete O, Bilgic B, Buyukbabani N. A tumor with many faces:
metastatic malignant melanoma with extensive cartilaginous
differentiation. Int J Surg Pathol 2010; 18:217–218. SFX [Context
Link]
4. Cachia AR, Kedziora AM. Subungual malignant melanoma with
cartilaginous differentiation. Am J Dermatopathol 1999; 21:165–169.
Ovid Full Text SFX [Context Link]
5. Boiko AD, Razorenova OV, van de Rijn M, et al. Human melanoma-
initiating cells express neural crest nerve growth factor receptor CD271.
Nature 2010; 466:133–137. SFX [Context Link]
6. Civenni G, Walter A, Kobert N, et al. Human CD271-positive
melanoma stem cells associated with metastasis establish tumor
heterogeneity and long-term growth. Cancer Res 2011; 71:3098–3109.
SFX [Context Link]
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
8 von 14 13.01.2017 13:53
7. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating
human melanomas. Nature 2008; 451:345–349. [Context Link]
8. White RM, Cech J, Ratanasirintrawoot S, et al. DHODH modulates
transcriptional elongation in the neural crest and melanoma. Nature
2011; 471:518–522. SFX [Context Link]
9[black small square]. Shakhova O, Zingg D, Schaefer SM, et al. Sox10
promotes the formation and maintenance of giant congenital naevi and
melanoma. Nat Cell Biol 2012; 14:882–890. SFX [Context Link]
Here we show that the neural crest transcription factor Sox10 is
expressed in the vast majority of giant congenital naevi and melanoma
samples. We demonstrate that Sox10 expression is regulated by
NrasQ61K oncogene. Sox10 haploinsufficiency prevents melanoma
formation without affecting the physiological functions of neural crest
derivatives. SOX10 silencing in human melanoma cells affected
cell-cycle progression, cell survival and completely abolished in-vivo
tumor formation. Taken together, these results suggest that SOX10
represents a novel therapeutic target for melanoma therapy.
10[black small square]. Cronin JC, Watkins-Chow DE, Incao A, et al.
SOX10 ablation arrests cell cycle, induces senescence, and suppresses
melanomagenesis. Cancer Res 2013; 73:5709–5718. SFX [Context
Link]
Together with [9[black small square]] shows that SOX10 is crucial for
the maintenance and survival of melanoma cells. Sox10
haploinsufficiency reduces the number of pigmented naevi and delays
melanoma formation in vivo. Silencing SOX10 expression in human
melanoma cells leads to cell cycle arrest in G1 phase via reduction in
E2F1 and retinoblastoma protein levels.
11. Stem Book, Shakhova O, Sommer L. Neural crest-derived stem
cells. 2008. [Context Link]
12. Kruger GM, Mosher JT, Bixby S, et al. Neural crest stem cells
persist in the adult gut but undergo changes in self-renewal, neuronal
subtype potential, and factor responsiveness. Neuron 2002;
35:657–669. SFX [Context Link]
13. Li HY, Say EH, Zhou XF. Isolation and characterization of neural
crest progenitors from adult dorsal root ganglia. Stem Cells 2007;
25:2053–2065. SFX [Context Link]
14. Nagoshi N, Shibata S, Kubota Y, et al. Ontogeny and multipotency
of neural crest-derived stem cells in mouse bone marrow, dorsal root
ganglia, and whisker pad. Cell Stem Cell 2008; 2:392–403. SFX
[Context Link]
15. Tomita Y, Matsumura K, Wakamatsu Y, et al. Cardiac neural crest
cells contribute to the dormant multipotent stem cell in the mammalian
heart. J Cell Biol 2005; 170:1135–1146. SFX [Context Link]
16. El-Helou V, Beguin PC, Assimakopoulos J, et al. The rat heart
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
9 von 14 13.01.2017 13:53
contains a neural stem cell population; role in sympathetic sprouting
and angiogenesis. J Mol Cell Cardiol 2008; 45:694–702. SFX
[Context Link]
17. Pardal R, Ortega-Saenz P, Duran R, Lopez-Barneo J. Glia-like stem
cells sustain physiologic neurogenesis in the adult mammalian carotid
body. Cell 2007; 131:364–377. SFX [Context Link]
18. Yoshida S, Shimmura S, Nagoshi N, et al. Isolation of multipotent
neural crest-derived stem cells from the adult mouse cornea. Stem
Cells 2006; 24:2714–2722. SFX [Context Link]
19. Brandl C, Florian C, Driemel O, et al. Identification of neural crest-
derived stem cell-like cells from the corneal limbus of juvenile mice. Exp
Eye Res 2009; 89:209–217. SFX [Context Link]
20. Stevens A, Zuliani T, Olejnik C, et al. Human dental pulp stem cells
differentiate into neural crest-derived melanocytes and have label-
retaining and sphere-forming abilities. Stem Cells Dev 2008;
17:1175–1184. [Context Link]
21. Coura GS, Garcez RC, de Aguiar CB, et al. Human periodontal
ligament: a niche of neural crest stem cells. J Periodontal Res 2008;
43:531–536. SFX [Context Link]
22. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent
adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;
3:778–784. SFX [Context Link]
23. Fernandes KJ, McKenzie IA, Mill P, et al. A dermal niche for
multipotent adult skin-derived precursor cells. Nat Cell Biol 2004;
6:1082–1093. SFX [Context Link]
24. Sieber-Blum M, Grim M, Hu YF, Szeder V. Pluripotent neural crest
stem cells in the adult hair follicle. Dev Dyn 2004; 231:258–269.
[Context Link]
25. Belicchi M, Pisati F, Lopa R, et al. Human skin-derived stem cells
migrate throughout forebrain and differentiate into astrocytes after
injection into adult mouse brain. J Neurosci Res 2004; 77:475–486.
SFX [Context Link]
26. Toma JG, McKenzie IA, Bagli D, Miller FD. Isolation and
characterization of multipotent skin-derived precursors from human
skin. Stem Cells 2005; 23:727–737. SFX [Context Link]
27. Wong CE, Paratore C, Dours-Zimmermann MT, et al. Neural crest-
derived cells with stem cell features can be traced back to multiple
lineages in the adult skin. J Cell Biol 2006; 175:1005–1015. [Context
Link]
28[black small square][black small square]. Johnston AP, Naska S,
Jones K, et al. Sox2-mediated regulation of adult neural crest
precursors and skin repair. Stem Cell Reports 2013; 1:38–45. SFX
[Context Link]
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
10 von 14 13.01.2017 13:53
In this paper, the authors show that adult neural crest precursors are
functionally important for the healing of adult skin. They demonstrate
that Sox2 marks the neural crest cell population associated with nerve
terminals around the hair follicular bulge. Upon skin injury, Sox2-positive
cells proliferate and migrate into the healing tissue. Genetic ablation of
Sox2 in adult mice decreased the rate of wound closure and impaired
wound healing. These results demonstrate that nerve-derived neural
crest precursors may play an important role in mammalian tissue repair.
29. Kumar A, Brockes JP. Nerve dependence in tissue, organ, and
appendage regeneration. Trends Neurosci 2012; 35:691–699. SFX
[Context Link]
30. Wegner M. From head to toes: the multiple facets of Sox proteins.
Nucleic Acids Res 1999; 27:1409–1420. SFX [Context Link]
31. Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in
patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;
18:171–173. SFX [Context Link]
32. Finzsch M, Schreiner S, Kichko T, et al. Sox10 is required for
Schwann cell identity and progression beyond the immature Schwann
cell stage. J Cell Biol 2010; 189:701–712. SFX [Context Link]
33[black small square][black small square]. Harris ML, Buac K,
Shakhova O, et al. A dual role for SOX10 in the maintenance of the
postnatal melanocyte lineage and the differentiation of melanocyte stem
cell progenitors. PLoS Genet 2013; 9:e1003644. SFX [Context Link]
In this paper, homozygous ablation of Sox10 specifically in the
melanocytic lineage results in loss of melanocyte stem cells and
differentiated melanocytes, effects leading to hair graying. Interestingly,
overexpression of Sox10 also leads to the loss of melanocyte stem cells
and hair graying, suggesting that the levels of Sox10 are critical for the
maintenance of normal melanocyte stem cells.
34. Paratore C, Goerich DE, Suter U, et al. Survival and glial fate
acquisition of neural crest cells are regulated by an interplay between
the transcription factor Sox10 and extrinsic combinatorial signaling.
Development 2001; 128:3949–3961. SFX [Context Link]
35. Britsch S, Goerich DE, Riethmacher D, et al. The transcription factor
Sox10 is a key regulator of peripheral glial development. Genes Dev
2001; 15:66–78. SFX [Context Link]
36. Potterf SB, Mollaaghababa R, Hou L, et al. Analysis of SOX10
function in neural crest-derived melanocyte development: SOX10-
dependent transcriptional control of dopachrome tautomerase. Dev Biol
2001; 237:245–257. SFX [Context Link]
37. Nishimura EK, Jordan SA, Oshima H, et al. Dominant role of the
niche in melanocyte stem-cell fate determination. Nature 2002;
416:854–860. SFX [Context Link]
38. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying:
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
11 von 14 13.01.2017 13:53
incomplete melanocyte stem cell maintenance in the niche. Science
2005; 307:720–724. SFX [Context Link]
39. Fuchs S, Herzog D, Sumara G, et al. Stage-specific control of
neural crest stem cell proliferation by the small rho GTPases Cdc42 and
Rac1. Cell Stem Cell 2009; 4:236–247. SFX [Context Link]
40. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights
into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008;
9:690–701. SFX [Context Link]
41. Thomas PS, Kim J, Nunez S, et al. Neural crest cell-specific
deletion of Rac1 results in defective cell-matrix interactions and severe
craniofacial and cardiovascular malformations. Dev Biol 2010;
340:613–625. SFX [Context Link]
42[black small square]. Krauthammer M, Kong Y, Ha BH, et al. Exome
sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Nat Genet 2012; 44:1006–1014. SFX [Context Link]
Exome sequencing of 147 human melanomas identifies an activating
mutation in RAC1 gene in 9.2% of sun-exposed melanomas. These
data demonstrate that RAC1P29S is the third most common mutation in
melanoma after BRAF and NRAS. RAC1P29S induces ERK
phosphorylation, increased proliferation and migration in normal human
melanocytes.
43[black small square]. Hodis E, Watson IR, Kryukov GV, et al. A
landscape of driver mutations in melanoma. Cell 2012; 150:251–263.
SFX [Context Link]
Together with [42[black small square]] shows that 3.9% of human
melanoma carry RAC1P29S oncogenic mutation. Structural analysis
reveals that RAC1P29S mutation is an activating mutation leading to a
unique conformational change in the switch I loop.
44[black small square]. Li A, Ma Y, Jin M, et al. Activated mutant
NRas(Q61K) drives aberrant melanocyte signaling, survival, and
invasiveness via a Rac1-dependent mechanism. J Invest Dermatol
2012; 132:2610–2621. SFX [Context Link]
In this study authors show that NrasQ61K -mediated survival of
melanocytes is Rac1-dependent. Rac1-deficient allografts display
delayed NrasQ61K-mediated melanoma growth in vivo. Pharmacological
inhibition of Rac1 using NSC23766 and EHT1864 also significantly
inhibited melanoma growth.
45. Qiu RG, Chen J, Kirn D, et al. An essential role for Rac in Ras
transformation. Nature 1995; 374:457–459. SFX [Context Link]
46. Dalton LE, Kamarashev J, Barinaga-Rementeria Ramirez I, et al.
Constitutive RAC activation is not sufficient to initiate melanocyte
neoplasia but accelerates malignant progression. J Invest Dermatol
2013; 133:1572–1581. SFX [Context Link]
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
12 von 14 13.01.2017 13:53
47. Schnelzer A, Prechtel D, Knaus U, et al. Rac1 in human breast
cancer: overexpression, mutation analysis, and characterization of a
new isoform, Rac1b. Oncogene 2000; 19:3013–3020. SFX [Context
Link]
48. Jordan P, Brazao R, Boavida MG, et al. Cloning of a novel human
Rac1b splice variant with increased expression in colorectal tumors.
Oncogene 1999; 18:6835–6839. SFX [Context Link]
49. Kamai T, Yamanishi T, Shirataki H, et al. Overexpression of RhoA,
Rac1, and Cdc42 GTPases is associated with progression in testicular
cancer. Clin Cancer Res 2004; 10:4799–4805. SFX [Context Link]
50. Pan Y, Bi F, Liu N, et al. Expression of seven main Rho family
members in gastric carcinoma. Biochem Biophys Res Commun 2004;
315:686–691. SFX [Context Link]
51. Mendoza-Catalan MA, Cristobal-Mondragon GR, Adame-Gomez J,
et al. Nuclear expression of Rac1 in cervical premalignant lesions and
cervical cancer cells. BMC Cancer 2012; 12:116. SFX [Context Link]
52. Chen QY, Xu LQ, Jiao DM, et al. Silencing of Rac1 modifies lung
cancer cell migration, invasion and actin cytoskeleton rearrangements
and enhances chemosensitivity to antitumor drugs. Int J Mol Med 2011;
28:769–776. SFX [Context Link]
53. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour
formation by single human melanoma cells. Nature 2008; 456:593–598.
SFX [Context Link]
54. Quintana E, Shackleton M, Foster HR, et al. Phenotypic
heterogeneity among tumorigenic melanoma cells from patients that is
reversible and not hierarchically organized. Cancer Cell 2010;
18:510–523. SFX [Context Link]
55. Shakhova O, Sommer L. Testing the cancer stem cell hypothesis in
melanoma: the clinics will tell. Cancer Lett 2012; 338:74–81. [Context
Link]
56[black small square][black small square]. Driessens G, Beck B,
Caauwe A, et al. Defining the mode of tumour growth by clonal analysis.
Nature 2012; 488:527–530. SFX [Context Link]
Using genetic lineage tracing and clonal analysis, the authors analyzed
benign skin papillomas and invasive skin carcinomas for the presence
of cancer stem cells. Invasive squamous carcinomas were sustained by
a single fast proliferating cell population, displaying limited
differentiation potential.
57[black small square][black small square]. Chen J, Li Y, Yu TS, et al. A
restricted cell population propagates glioblastoma growth after
chemotherapy. Nature 2012; 488:522–526. SFX [Context Link]
Ovid: Neural crest stem cells in melanoma development. http://ovidsp.tx.ovid.com/sp-3.23.1b/ovidweb.cgi?QS2=434f4e1a73d3...
13 von 14 13.01.2017 13:53
Select All Export Selected to PowerPoint
< Previous Article Table of Contents Next Article >
In this study, the authors generated a mouse model, which allows to
specifically eliminate Nestin-positive cells in tumor-bearing mice by
utilizing ganciclovir. Sequential administration of temozolomide and
ganciclovir resulted in the efficient depletion of tumors. Importantly,
authors demonstrate that only cancer stem cells sustain tumor
formation and are responsible for tumor recurrence in this model.
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